SCHEMBL6878671

SCHEMBL6878671

Cc1ccc(N(N)C(=O)OC(C)(C)C)cc1C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.36
RXRA P19793 2/20 0.35
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
TAS2R14 Q9NYV8 1/20 0.35
ALKBH5 Q6P6C2 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1C Q13936 1/20 0.34
POLQ O75417 2/20 0.33
GPBAR1 Q8TDU6 1/20 0.32
PAX8 Q06710 1/20 0.32
RHEB Q15382 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NOTUM Q6P988 1/20 0.32
KCNN4 O15554 1/20 0.31
PGR P06401 1/20 0.31
AR P10275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17336857 0.89 LMNA (0.36) LMNAPOLBRXRANR1H2NR1H3
SCHEMBL6881686 0.85 KDR (0.41) LMNANOTUM
SCHEMBL14740800 0.84 LMNA (0.34) LMNAPOLBPAX8MEN1KMT2A
SCHEMBL6879948 0.83 KIF11 (0.40) LMNAPOLBRXRANR1H2NR1H3
SCHEMBL27827952 0.83 MT-CO2 (0.32) PAX8MT-CO2
SCHEMBL6879931 0.81 MRGPRX4 (0.37) LMNAPOLBRXRANR1H2NR1H3
SCHEMBL6879592 0.81 NR1H2 (0.39) LMNAPOLBRXRANR1H2NR1H3
SCHEMBL2529611 0.78 MT-CO2 (0.42) PAX8NOTUMMT-CO2
SCHEMBL6623841 0.78 RXRA (0.37) LMNAPOLBRXRANR1H2NR1H3
SCHEMBL6877992 0.78 POLQ (0.37) LMNAPOLBRXRANR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed